DMARDs and the JAK Inhibitors have improved RA treatment. But not many new drugs are in the offing at the moment.
Erin Johanek, PharmD
The first FDA-approved product for NASH on the horizon.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.